Login

Jesper Söderqvist, CEO, Boule Diagnostics 00:00:00

Share On Facebook Share On Twitter

Boule´s CEO, Jesper Söderqvist, present the interim report

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
David Azerad discusses his contribution to the paleoconservative anthology and his relationship with Paul Gottfried.|David Azerrad,Professor,Hillsdale College
00:10:00
Building Back Better: Harnessing Emerging Talent | Leo Quinn - CEO of Balfour Beatty
00:10:00
Barrick Highlights Strategic Growth in Gold and Copper Mining
00:10:00
The Importance of Trust and Quality in Consulting and Management
00:10:00
Global solidarity on World AIDS Day calls for increased funding |Richard Eberly, CEO, Chembio Diagnostics Inc.
00:10:00
Driving Value Through Diversification: Elemental Royalties Corp CEO Frederick Bell Shares Insights
00:10:00
From the Helm: Lindsay Partridge on Brickworks' Growth and Dividend Success | Lindsay Partridge - CEO of brickworks ltd
00:10:00
Austco Healthcare improving the experience for patients and caregivers|CEO,Azure Healthcare Ltd
00:10:00
Seamless Remote Work Transition with M-Files Cloud-Based Management
00:10:00
Rick & Aisha: Inspiring Sponsorship Stories at Kirkland | Jeffrey C. Hammes - CEO of Kirkland & Ellis LLP
00:10:00
Going Public: Ankit Mehta Discusses IdeaForge Tech's Fast-Subscribed IPO | Ankit Mehta , CEO, ideaForge Technology Ltd.
00:10:00
Simone Veglioni Discusses Vantea Smart's Growth and Cybersecurity Focus| Simone Veglioni, CEO , Vantea Smart SPA.

© 2026 Nehu